BioNexus Gene Lab (BGLC) Change in Acquisitions & Divestments (2021 - 2024)
Historic Change in Acquisitions & Divestments for BioNexus Gene Lab (BGLC) over the last 3 years, with Q4 2024 value amounting to $574036.0.
- BioNexus Gene Lab's Change in Acquisitions & Divestments rose 8117853.11% to $574036.0 in Q4 2024 from the same period last year, while for Mar 2025 it was $857433.0, marking a year-over-year increase of 26103.96%. This contributed to the annual value of $1.1 million for FY2024, which is 398772.66% up from last year.
- As of Q4 2024, BioNexus Gene Lab's Change in Acquisitions & Divestments stood at $574036.0, which was up 8117853.11% from $197063.0 recorded in Q3 2024.
- BioNexus Gene Lab's Change in Acquisitions & Divestments' 5-year high stood at $574036.0 during Q4 2024, with a 5-year trough of -$708.0 in Q4 2023.
- Over the past 3 years, BioNexus Gene Lab's median Change in Acquisitions & Divestments value was $56594.0 (recorded in 2023), while the average stood at $136856.1.
- Over the last 5 years, BioNexus Gene Lab's Change in Acquisitions & Divestments had its largest YoY gain of 8117853.11% in 2024, and its largest YoY loss of 63383.11% in 2024.
- Quarter analysis of 3 years shows BioNexus Gene Lab's Change in Acquisitions & Divestments stood at -$22.0 in 2021, then tumbled by 3118.18% to -$708.0 in 2023, then soared by 81178.53% to $574036.0 in 2024.
- Its Change in Acquisitions & Divestments stands at $574036.0 for Q4 2024, versus $197063.0 for Q3 2024 and $86334.0 for Q2 2024.